New York State Common Retirement Fund Viking Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 112,698 shares of VKTX stock, worth $4.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,698
Previous 118,898
5.21%
Holding current value
$4.49 Million
Previous $3.15 Million
8.63%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding VKTX
# of Institutions
438Shares Held
66.7MCall Options Held
7.21MPut Options Held
3.87M-
Vanguard Group Inc Valley Forge, PA10MShares$398 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA4.51MShares$180 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.73MShares$148 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.58MShares$103 Million0.0% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...